Subsequently, we analyzed whether a ratio of neurodegeneration to synaptic dysfunction (specifically, NFL compared to SNAP-25 or NPTX2 and tau compared to SNAP-25 or NPTX2) would more effectively differentiate patients with delirium from control groups (AD and non-AD). This evidence concerns the gene MAPT and delirium.